Mainz Biomed B.V. (MYNZ)
5.09
-0.09 (-1.74%)
At close: Jan 29, 2025, 3:58 PM
5.13
0.76%
After-hours Jan 29, 2025, 07:56 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -26.30M | -26.39M | -11.69M | -586.89K | -957.05K |
| Depreciation & Amortization | 866.41K | 379.80K | 69.93K | 60.46K | 53.04K |
| Stock-Based Compensation | 4.01M | 9.82M | 6.43M | n/a | n/a |
| Other Working Capital | -300.22K | -1.82B | -162.83K | 156.74K | 83.41K |
| Other Non-Cash Items | -450.53K | 26.79K | 2.11M | 107.00 | 64.48K |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | -64.63K | 1.39M | -138.62K | 57.59K | 423.04K |
| Operating Cash Flow | -21.94M | -14.77M | -3.22M | -468.74K | -416.50K |
| Capital Expenditures | -1.90M | -658.48K | -16.70K | -9.69K | n/a |
| Acquisitions | n/a | n/a | 1.22M | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -700.00K | n/a | 1.22M | n/a | n/a |
| Investing Cash Flow | -1.90M | -658.48K | 1.20M | -9.69K | n/a |
| Debt Repayment | 7.83M | -197.94K | 185.37K | 371.35K | 424.00K |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | n/a | 275.47K | n/a | 25.33K | n/a |
| Financial Cash Flow | 14.23M | 23.94M | 10.61M | 396.68K | 424.00K |
| Net Cash Flow | -10.07M | 8.41M | 8.60M | -81.02K | -25.94K |
| Free Cash Flow | -23.84M | -15.43M | -3.24M | -478.42K | -416.50K |